Luigi Moretti

MEMOPAD: Multimodal Emotion Monitoring in Clinical Pathways for Anxiety Disorders

Luigi Moretti, Miles Thompson, Paul Matthews, Michael Loizou et autres

gb (code pays fourni par la source)

Towards deployment-centric multimodal AI beyond vision and language

Xianyuan Liu, Jiayang Zhang, Shuo Zhou, Thijs L. van der Plas et autres

gb, no, hk (code pays fourni par la source)

Clinical AI Scribes in primary care: accuracy, error severity and implications for clinical practice

Thomas C. Draper, Timothy M. Cox, Kathryn Lamb-Riddell, Luigi Moretti et autres

Objectives: To investigate the performance of commercially available Clinical Artificial Intelligence Scribes (CAISs), assessing their accuracy, potential clinical impact of errors, and documentation quality, given growing concerns around errors and safety. Methods and analysis: Seven CAIS products were investigated, using eight standardised …

gb (code pays fourni par la source)

Towards deployment-centric multimodal AI beyond vision and language

Xianyuan Liu, Jiayang Zhang, Shuo Zhou, Thijs L. van der Plas et autres

Multimodal artificial intelligence (AI) integrates diverse types of data via machine learning to improve understanding, prediction, and decision-making across disciplines such as healthcare, science, and engineering. However, most multimodal AI advances focus on models for vision and language data, while their deployability …

PD-L1 Expression in Paired Samples of Rectal Cancer

Mina Coussement, Roberta Fazio, Alessandro Audisio, Reem El Khoury et autres

Immune checkpoint inhibitors and immune-related biomarkers are increasingly investigated in rectal cancer (RC). We retrospectively analysed PD-L1 expression in diagnostic biopsy and resection samples from RC patients treated at our centre between 2000 and 2020. PD-L1 immunostaining (22C3 clone) was evaluated according …

be (code pays fourni par la source)

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

Guillaume Roger, Grégory Ducrocq, Jules Mesnier, Neila Sayah et autres

BACKGROUND AND AIMS: It has been reported that patients without standard modifiable cardiovascular (CV) risk factors (SMuRFs-diabetes, dyslipidaemia, hypertension, and smoking) presenting with first myocardial infarction (MI), especially women, have a higher in-hospital mortality than patients with risk factors, and possibly a …

fr, it, gb, ca, pl (code pays fourni par la source)

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, Laurine Verset et autres

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest tumors with slow progress in systemic therapies due to its peculiar and resistant tumor microenvironment. Inclusion of isotoxic high-dose stereotactic body radiation therapy (iHD-SBRT) into a total neoadjuvant strategy (TNT) is promising for …

be, sk, cz, jp, fr (code pays fourni par la source)

Supplementary Fig. S2 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey et autres

Supplementary Fig. S2 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Supplementary Fig. S1 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey et autres

Supplementary Fig. S1 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Data from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey et autres

Abstract Despite recent advances in the management of breast and lung cancer, novel treatment strategies are still needed to further improve patient outcome. The targeting of cell death pathways has therefore been proposed to enhance therapeutic ratio in cancer. In this study, …

Data from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey et autres

Abstract Despite recent advances in the management of breast and lung cancer, novel treatment strategies are still needed to further improve patient outcome. The targeting of cell death pathways has therefore been proposed to enhance therapeutic ratio in cancer. In this study, …

Supplementary Fig. S1 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor

Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey et autres

Supplementary Fig. S1 from Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor